Clinical Trial Update: A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating docetaxel, oxaliplatin, and S-1 in patients with unresectable locally advanced or lymph node–limited metastatic gastric can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Taxotere (docetaxel)

Snippet

Sponsor: Asan Medical Center | Conditions: Stomach Neoplasm | Phase 2 | Status: RECRUITING